The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Will's statement is designed to mislead with a view to market manipulation. It was clearly stated as a known fact by him - no ambiguity in what was said so it has crossed a serious line. There is no fact or evidence in the public domain that substantiates the statement. He (or she) has made a serious mis-representation and so his post should be brought to the attention of the board administrators with a view to taking appropriate action in line with board rules.
to being the first to post on the LSE site for the new ticker!
Let's hope the new name, new website etc bring a new set of positive developments and a sustained growth in the share price.
Just to re-iterate, new website address is www.yourgene-health.com. Personally not a fan of hyphen's in website addresses! Also note that the domain name www.yourgene.com is currently taken but marketed for sale by current owner!
BPC are closing this down for the foreseeable future and MQ will receive their payout and appreciation for their efforts. Unfortunately in the too difficult pile but just like a squirrel hibernating there will be another effort in the spring of next year. Thanks for all the effort and optimism in the spring and summer this year but just not ready yet, the environment will improve as long as we conserve our efforts. Don’t be too disheartened and take advantage of the buying opportunity over the next 6 months for even greater rewards this time next year. Hang on in there LTH’s and buy down to 0.6p or so.
Suspect that if these were to hit 1p they would only do so on the way to a much lower level and pretty much a Terminal position. At the moment there is an outside chance of a deal (hopefully not one that wipes existing shareholders out) hence the price persists at these levels (there or thereabouts). I’d rather invest here with some betting money than at 1p where some bad news, most likely, would have emerged.
What a wimp. Was down £250k on GKP at one point but slightly in profit now. At one point was £500k down on Glencore but closed position for a profit of nearly £700k. Just a case of believing in what you take positions in, but I have to admit Prem has tested my faith! PS Steve - I have almost 1.5m shares in Prem to answer you question of Fri when I had my hissy fit about the continued disappointment about them failing to deliver something close to what they had previously said they would deliver.
Have reflected and spent time reading the results and statements in some detail over the course of this morning. Clearly I was somewhat over emotional at the seeming large step back after the high of the recent agreement with Illumina!!! Interested in the detail (albeit from TW) on the clusterf**k that was the FinCap attempt of carrying out the placing. Will definitely NOT be selling and will buy more at 10p (if it drops 20% or more to flush out weak holders) tomorrow morning to maintain my proportionate holding. ATB
I totally agree further fund raises are needed with absolute certainty just to keep the lights on. There is now a very high probability that the business will not make it to this time next year. The board have duped existing shareholders about break even timescales. I will be dumping my shares at pretty much any price on Monday and stick by my prediction this will test all time lows within the next week. The US market will not exist when the Reps eventually get past nomination calamities with Kavanaugh and confirm some other right wing judge to the Supreme Court and the pro life brigade gets its way on abortion.
I think it is fantasy island they will raise the funds at 10p - i can see this crashing 50% on Monday and maybe even test the low point when the court case result was announced last November. £700k is peanuts to Dr Bill Chang, so not sure how much strength to place in that. Feel totally mislead at this point by the statements of the spring on nearing operational breakeven and TW's excessive, repeated misplaced confidence - would not be surprised to find he was selling into the recent rise post Illumina settlement. This is an utter car crash set of results.
brainspark - very much respect your view. i can't see beyond the level of admin expenses (ignoring the litigation costs) at the moment that implies such a large increase in revenue to reach break even from here soon. appreciate that test volumes are ramping up (and hopefully will very much accelerate) but the results just seem very disappointing to me. will be good to see an updated Hardman report ASAP.
it's the 9m admin expenses that kills this for me. with the margin of 52% (seems good in isolation) it seems implausible they can increase revenues even in the next financial year to reach breakeven so numerous cash calls to come. with impact that will have on SP the raises will be very dilutive for existing s/h's. snatching quick looks at the RNS so hopefully i have missed something - please someone tell me there are some positives here? is this a business that will ever make money in this field or will volumes always just be too low absent developing other tests (where volume market for them will justify the investment)?
No wonder we haven't heard much from the new CEO - must have thought what the f have i let myself into! until now hadn't contemplated the biggest risk as we are in danger of going to the wall rather than the legal battle with Illumina.
Clearly reality is the opposite of what TW predicts! Was the 25p by Xmas? Based on these results absolutely zero chance of that - would have thought holding the placing price of 10p by the end of the year will be a big bonus. Not convinced they will easily get the placing away at 10p - can see the market brutally saying what it thinks about Prem on Monday at opening. The battle with Illumina has certainly taken a huge toll.
Suggests the results are pretty disappointing and not close to operational break-even at the end of financial year 2018 (ie as at 312/03/2018). Will they struggle to get the placing away at 10p? Also not a major dipping of directors into their own pockets as part of the placing (given how minted Bill Chang is especially)?
But what is due is the accounts for the financial year ending 31/03/2018 - they are not unaudited interim results.
Companies House says accounts for financial year ending 31/03/2018 are due by 31/12/2018.
Do they have to be reported within 6 months of the YE date or would reporting before market opens On Monday also satisfy the market requirements? Haven’t checked rule on this but suspect it is former and as 1 October is Monday and there can’t be a Sat or Sun RNS then it has to be today at some point otherwise they are in breach of market requirements and trading in their shares will be suspended?
You have forgotten that this is a historical summary of what actually happened in the reporting period and in itself does not tell us anything we don’t already know. So yes the EA was lodged. What we have speculated on this board is that the EA isn’t granted until full details of the proposed drill are known, including identity of drill partner. My view remains that a well will never be drilled if BPC doesn’t have a partner for a drill (and that will need to be at least a major to get EA approval).
Chapsand chapesses. Just spent a nice evening drinking in the Black Horse near the site. Hoping to eavesdrop on conversations relating to HH but sadly nothing! Enjoyed the beer though but not the mega early flight from Gatwick in the morning though!
No not NIPT results, but just cracking myself up watching the Trump press conference post UN General Assembly on US media! Can I patent the expression “****wit ++”. Fully expect an RNS tomorrow rather than Friday on the NIPT results and expecting them to propel us to the next level.
Potter jargon bingo - everyone get their pens ready!! Don’t think he missed any of his favourite BS in that interview!